AIDS by mother-to-child transmission: Survival analysis of cases followed from 1983 to 2002 in different regions of Brazil

Cadernos de Saude Publica

Volumn 23, Issue SUPPL. 3, 2007, Pages

  Matida, Luiza Harunari ^a   Ramos Jr , Alberto Novaes ^b   Moncau, José Eduardo Cajado ^g   Marcopito, Luiz Francisco ^c   Marques, Heloisa Helena De Sousa ^d   Succi, Regina Célia Menezes ^c   Negra, Marinella Della ^e   Hearst, Norman ^f   Apolinario Jr J C ^g   Barbosa Jr , A ^g   Bertolini, D V ^g   Caminada, S ^g   Castro, A M M ^g   Cervi, M C ^g   Costa, B V ^g   Guibu, A ^g   Guzzo, P ^g   Landroni, I M A S ^g   Machado, D M ^g   Santos, N J S ^g   Sato, H K ^g   Sauer, M M ^g   Silva, C L O ^g   Souza, E S ^g   Fonseca, M G P ^g   Waldman, E ^g   more..

^a Centro de Referência e Treinamento em DST Aids   (Brazil)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g NONE

Author keywords

Acquired immunodeficiency syndrome; Health inequalities; HIV; Survival analysis; Vertical disease transmission

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BRAZIL; CHILD; COHORT ANALYSIS; DISEASE TRANSMISSION; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MALE; MORTALITY; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PRESCHOOL CHILD; PUBLIC HEALTH; SOCIAL JUSTICE; SOCIOECONOMICS; STATISTICS; SURVIVAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BRAZIL; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE TRANSMISSION, VERTICAL; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MALE; NATIONAL HEALTH PROGRAMS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SOCIAL JUSTICE; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS;

EID: 36849061228     PISSN: 0102311X     EISSN: 16784464     Source Type: Journal    
DOI: 10.1590/S0102-311X2007001500011     Document Type: Article

References (43)

1. The Joint United Programme on HIV/AIDS. AIDS epidemic update, December 2005. Geneva: Joint United Nations Programme on HIV/AIDS/World Health Organization; 2005.
2. Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, D'Arminio MA, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003; 362:22-9.
3. Resino S, Bellón JM, Resino R, Navarro ML, Ramos JT, José MI, et al. Extensive implementation of highly active antiretroviral therapy shows great effect on survival and surrogate markers in vertically HIV-infected children. Clin Infect Dis 2004; 38:1605-12.
4. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1999; 349:1269-76.
5. Houweling TA, Kunst AE, Malkenbach JP. World Health Report 2000: inequality index and socioeconomic inequalities in mortality. Lancet 2001; 357:1671-2.
6. Wood E, Montaner JS, Chan K, Tyndall MW, Schechter MT, Bangsberg D, et al. Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996. AIDS 2002; 16:2065-72.
7. Shapiro K, Benatar SR. HIV prevention research and global inequality: steps towards improved standards of care. J Med Ethics 2005; 31:39-47.
8. Poundstone KE, Strathdee SA, Celentano DD. The social epidemiology of human immunodeficiency virus/acquired immunodeficiency syndrome. Epidemiol Rev 2004; 26:22-35.
9. The Joint United Programme on HIV/AIDS. AIDS epidemic update, December 2004. Geneva: Joint United Nations Programme on HIV-AIDS/World Health Organization; 2004
10. Gortmaker SL, Hughes M, Cervia J, Brady M, Johnson GM, Seage GR, et al. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Eng J Med 2001; 345:1522-8.
11. Fordyce EJ, Singh TP, Nash D, Gallagher B, Forlenza S. Survival rates in NYC in the era of combination ART. J Acquir Immune Defic Syndr 2002; 30:111-8.
12. Popp D, Fisher JD. First, do no harm: a call for emphasizing adherence and HIV prevention interventions in active anti-retroviral therapy programs in the developing world. AIDS 2002; 16:676-8.
13. United Nations Children's Fund. Progress for children, volume 1; 2004. http://www.unicef. org/progressforchildren/2004v1 (accessed on 30/Mar/2006).
14. Ministério da Saúde. Apresentação. Boletim Epidemiológico AIDST 2005; Ano II; no. 1.
15. Ministério da Saúde. Recomendações para profilaxia da transmissão vertical do HIV e terapia anti-retroviral em gestantes. Brasília: Ministério da Saúde; 2004.
16. Kaplan EL, Meier P. Non parametric estimation from incomplete observation. J Am Stat Assoc 1958; 53:457-81.
17. Lee LM, Karon JM, Selik R, Neal JJ, Fleming PL. Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1984-1997. JAMA 2001; 285:1308-15.
18. Kleinbaum DG. Survival analysis: a self-learning text. New York: Springer-Verlag; 1995.
19. Cox DR, Oakes D. Analysis of survival data. London: Chapman & Hall; 1984.
20. Matida LH, Marcopito LF, Succi RCM, Marques HHS, Della Negra M, Grangeiro A, et al. Improving survival among Brazilian children with perinatal-acquired AIDS. Braz J Infect Dis 2004; 8:419-23.
21. Ministério da Saúde. Recomendações para terapia anti-retroviral em crianças infectadas pelo HIV. Brasília: Ministério da Saúde; 2004.
22. Ministério da Saúde. Recomendações para terapia anti-retroviral em adultos e adolescentes. Brasília: Ministério da Saúde; 2004.
23. European Collaborative Study. Natural history of vertically acquired human immunodeficiency virus-1 infection. Pediatrics 1994; 94:815-9.
24. Tovo P, Gabiano C, Palomba E, De Martino M, Galli L, Capello N, et al. Prognostic factors and survival in children with perinatal HIV-1 infection. Lancet 1992; 339:1249-53.
25. Grubman S, Gross E, Lerner-Weiss N, Hernandez M, McSherry GD, Hoyt LG, et al. Older children and adolescents living with perinatally acquired human immunodeficiency virus infection. Pediatrics 1995; 95:657-63.
26. Chequer P, Hearst N, Hudes ES, Castilho E, Rutherford G, Loures L, et al. Determinants of survival in adult Brazilian AIDS patients, 1982-1989. AIDS 1992; 6:483-7.
27. Grangeiro A. O perfil sócio-econômico dos casos de AIDS na cidade de São Paulo. In: Parker R, Bastos C, Galvão J, Pedrosa JS, organizadores. A AIDS no Brasil. Rio de Janeiro: Editora Relume-Dumará; 1994. p. 91-128.
28. Matida LH. AIDS de transmissão materno-infantil: análise de sobrevivência dos casos notificados ao sistema oficial do Estado de São Paulo de 1987 a 1994. Rev Paul Pediatr 1999; 17:37-43.
29. Saulsbury FT. Resolution of organ-specific complications of human immunodeficiency virus infection in children with use of highly active antiretroviral therapy. Clin Infect Dis 2001; 32:464-8.
30. Cooper CL, Parbhakar MA, Angel JB. Hepatotoxicity associated with antiretroviral therapy containing dual versus single protease inhibitors in individuals coinfected with hepatitis C virus and human immunodeficiency virus. Clin Infect Dis 2002;34:1259-63.
31. Richman DD, Morton SC, Wrin T, Hellman N, Berry S, Shapiro MF, et al. The prevalence of antiretroviral drug resistance in the United States. AIDS 2004;18:1393-401.
32. Lindegren ML, Byers Jr. RH, Thomas P, Davis SF, Caldwell B, Rogers M, et al. Trends in perinatal HIV/AIDS in the United States. JAMA 1999; 282:531-8.
33. Abrams E, Weedon J, Bertolli J, Bornschlegel K, Cervia J, Mendez H, et al. Aging cohort of perinatally human immunodeficiency virus-infected children in New York City. Pediatr Infect Dis J 2001; 20:511-7.
34. De Martino M, Tovo P, Balducci MD, Galli L, Gabiano C, Rezza G, et al. Reduction in mortality with availability of anti-retroviral therapy for children with perinatal HIV-1 infection. JAMA 2000;284:190-7.
35. Dunn D. Short-term risk for disease progression in HIV-1 infected children receiving no anti-retroviral therapy or zidovudine monotherapy: a meta-analysis. Lancet 2003, 362:1605-11.
36. Rapiti E, Porta D, Forastiere F, Fusco D, Perucci C. Socioeconomic status and survival of persons with AIDS before and after the introduction of highly active antiretroviral therapy. Lazio AIDS Surveillance Collaborative Group. Epidemiology 2000;11:496-501.
37. Centers for Disease Control and Prevention. Survival after AIDS diagnosis. Atlanta: Centers for Disease Control and Prevention; 2002. (HIV/AIDS Surveillance Report, 14).
38. King SM. Progression of disease in HIV infected children slowed after the first year of life. Evid Based Med 2002; 7:27.
39. Barnhart HX, Caldwell MB, Thomas P, Mascola L, Ortiz I, Hsu WH, et al. Natural history of human immunodeficiency virus disease in perinatally infected children: an analysis from the Pediatric Spectrum of Disease Project. Pediatrics 1996;97:710-6.
40. Ministério da Saúde. Sobre a correção do atraso de notificação dos casos de AIDS no Brasil. Boletim Epidemiológico AIDS 2001; Ano XIV; no. 2.
41. Ministério da Saúde. Perspectiva histórica das definições de caso de AIDS no Brasil. Boletim Epidemiológico AIDS 2004; Ano XVII; no. 1.
42. Menesia EO, Costa Passos AD, Monteiro, ME, Dal-Fabbro AL, Laprega MR. Survival of AIDS patients in a city in southeastern Brazil. Rev Panam Salud Pública 2001; 10:29-36.
43. Succi RCM; Grupo de Estudos da Sociedade Brasileira de Pediatria. Transmissão vertical do HIV no Brasil em 2003-2004: resultado preliminar de um estudo colaborativo multicêntrico. In: XIV Congresso Brasileiro de Infectologia Pediátrica e III Jornada Paranaense de Infectologia Pediátrica. Recife: Sociedade Brasileira de Pediatria; 2006. p. S100.